Stéphane Bancel, Moderna CEO (Getty Images)
August 28, 2020 07:09 AM EDTUpdated 09:31 AM
Coronavirus

Covid-19 roundup: J&J launch­ing new PhII vac­cine tri­als in Eu­rope; Ab­bott scores $760M test­ing kit or­der from HHS

Max Gelman

Senior Editor

Nicole DeFeudis

Editor

Amber Tong

As J&J plans to roll out Phase III test­ing for its Covid-19 vac­cine some­time next month, the big phar­ma is plan­ning ad­di­tion­al Phase II tri­als …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times